Luther King Capital Management (LKCM)’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.42M Sell
645,047
-2,373
-0.4% -$31.4K 0.04% 194
2026
Q1
$8.92M Buy
647,420
+293,236
+83% +$4.42M 0.04% 187
2025
Q4
$6.39M Buy
354,184
+52,945
+18% +$951K 0.03% 224
2025
Q3
$5.58M Buy
+301,239
New +$4.73M 0.02% 234

Other funds holding CLBT

Luther King Capital Management (LKCM)'s CLBT Position: Q2 2026 in Review

Luther King Capital Management (LKCM) reduced its Cellebrite (CLBT) stake by 0.37% in Q2 2026, selling an estimated $31.4K and leaving 645,047 shares worth $9.42M. The position accounts for 0.04% of the portfolio, ranked #194.

Luther King Capital Management (LKCM) first reported a position in CLBT in Q3 2025 and has held it in 4 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Luther King Capital Management (LKCM) held 645,047 shares of Cellebrite worth $9.42M as of Q2 2026.
  • Luther King Capital Management (LKCM) sold 2,373 Cellebrite shares in Q2 2026, an estimated $31.4K.
  • Cellebrite made up 0.04% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #194 holding.
  • Luther King Capital Management (LKCM) first reported a position in Cellebrite in Q3 2025 and has held it in 4 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.